Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial

The glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine displays rapid antidepressant effects in patients with treatment-resistant depression (TRD); however, the potential for adverse neurocognitive effects in this population has not received adequate study. The current study was desi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuropsychopharmacology
Egile Nagusiak: Murrough, James W, Burdick, Katherine E, Levitch, Cara F, Perez, Andrew M, Brallier, Jess W, Chang, Lee C, Foulkes, Alexandra, Charney, Dennis S, Mathew, Sanjay J, Iosifescu, Dan V
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367458/
https://ncbi.nlm.nih.gov/pubmed/25374095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2014.298
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak